Clinical Trial Update: Dynesys Spinal System Post Market 522 Study [NA]

View source ↗

Summary

Clinical trial update for the Dynesys Spinal System post-market study has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Spondylolisthesis
• Pseudoarthrosis

Drugs mentioned

• Dynesys Spinal System

Snippet

Sponsor: Zimmer Biomet | Conditions: Degenerative Spondylolisthesis, Pseudoarthrosis | NA | Status: TERMINATED | Results posted: 2020-01-29